Ra Medical Systems (RMED) Misses Q3 EPS by 24c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Ra Medical Systems Reports Third Quarter 2018 Results
November 13, 2018 4:15 PM EST-Revenue increased nearly 60% year-over-year to $2.1 million
-Increased DABRA usage agreements 325% quarter-over-quarter
-Announced approval for long-term revascularization registry of DABRA system
CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc.(NYSE: RMED) (the Company), a commercial-stage medical device company leveraging its advanced, minimally-invasive excimer laser-based platform for use in the treatment of vascular and dermatological diseases, today reported its financial results for the three and nine-month period ended September 30, 2018.
The third quarter of 2018 was pivotal in our Companys history as... More



